Phase I trial of an alpha-lactalbumin vaccine in patients with moderate- to high-risk operable triple-negative breast cancer (TNBC).
Abstract
TPS1125
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jun 01, 2022
- Source ID
- 10.1200/jco.2022.40.16_suppl.tps1125
Entities
People
- Brenna Elliott
- Donna Lach
- Emily Esakov Rhoades
- Erin Elizabeth Roesch
- George Thomas Budd
- Halle C. F. Moore
- Jame Abraham
- Justin M. Johnson
- Megan Lynn Kruse
- Vincent K. Tuohy
Organizations
- Cleveland Clinic
- United States Department of Defense